Rigel Pharmaceuticals, Inc. revenue breakdown overview

Rigel Pharmaceuticals, Inc. revenue for the last year amounted to 116.88 M USD, the most of which — 116.88 M USD — came from its highest performing source at the moment, Novel Therapies, the year earlier bringing 120.24 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Rigel Pharmaceuticals, Inc. 116.88 M USD, and the year before that — 120.24 M USD.